Literature DB >> 27789672

Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.

Ivette Ag Deckers1, Manon van Engeland2, Piet A van den Brandt1, Leander Van Neste2, Patricia Mmb Soetekouw3, Maureen Jb Aarts3, Marcella Mll Baldewijns2,4, András P Keszei1,5, Leo J Schouten1.   

Abstract

Background: Sodium intake, but not potassium or fluid intake, has been associated with higher renal cell cancer (RCC) risk. However, risk factors may differ by molecular subtypes of the tumour. In renal physiology, electrolyte and water homeostasis is facilitated by ion transport mechanisms (ITM). Aberrant regulation of ITM genes, for example by promoter CpG island methylation, may modify associations between sodium, potassium and fluid intake and RCC risk.
Methods: We identified ARHGDIG , ATP1A1 , SCNN1B and SLC8A3 as ITM genes exhibiting RCC-specific promoter methylation and down-regulation. Methylation-specific polymerase chain reaction (PCR) was used to analyse promoter CpG island methylation in tumour DNA of 453 RCC cases from the Netherlands Cohort Study ( n = 120 852) after 20.3 years of follow-up. Diet was measured at baseline using food-frequency questionnaires. Cox regression analyses were restricted to clear-cell (cc)RCC ( n = 306) and stratified by tumours with no, low (1 gene) and high (≥ 2 genes) methylation.
Results: Sodium intake (high vs low) increased ccRCC risk particularly in tumours with a high methylation index: hazard ratio (HR) [95% confidence interval (CI)]: 2.04 (1.16-3.58), whereas heterogeneity across the methylation index was not significant ( P -heterogeneity = 0.26). Potassium intake was differentially associated with ccRCC risk ( P -heterogeneity = 0.008); the risk for high (vs low) potassium intake was low for unmethylated tumours [HR (95% CI): 0.60 (0.36-1.01)], but high for tumours with a high methylation index [HR (95% CI): 1.60 (0.96-2.65)]. Risks similarly differed for fluid intake, though not significantly ( P -heterogeneity = 0.54). Conclusions: Our findings suggest for the first time that dietary intakes are differentially associated with ccRCC risk according to molecular subtypes defined by ITM gene-specific promoter methylation.
© The Author 2016; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association

Entities:  

Keywords:  Promoter CpG island methylation; clear-cell renal cell cancer risk; dietary intakes; ion transport mechanisms; prospective cohort

Mesh:

Substances:

Year:  2017        PMID: 27789672     DOI: 10.1093/ije/dyw266

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

Review 1.  Dietary Reference Intakes of sodium for Koreans: focusing on a new DRI component for chronic disease risk reduction.

Authors:  Hyun Ja Kim; Yeon-Kyung Lee; Hoseok Koo; Min-Jeong Shin
Journal:  Nutr Res Pract       Date:  2022-03-16       Impact factor: 1.992

2.  Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.

Authors:  Chuangye Han; Tingdong Yu; Wei Qin; Xiwen Liao; Jianlu Huang; Zhengtao Liu; Long Yu; Xiaoguang Liu; Zhiwei Chen; Chengkun Yang; Xiangkun Wang; Shutian Mo; Guangzhi Zhu; Hao Su; Jiaquan Li; Xue Qin; Ying Gui; Zengnan Mo; Lequn Li; Tao Peng
Journal:  J Gastrointest Oncol       Date:  2020-12

3.  Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.

Authors:  Jia Wang; Qiujing Zhang; Qingqing Zhu; Chengxiang Liu; Xueli Nan; Fuxia Wang; Lihua Fang; Jie Liu; Chao Xie; Shuai Fu; Bao Song
Journal:  J Cell Physiol       Date:  2019-07-05       Impact factor: 6.384

4.  Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study.

Authors:  Jeroen A A van de Pol; Lisa George; Piet A van den Brandt; Marcella M L L Baldewijns; Leo J Schouten
Journal:  Int J Cancer       Date:  2020-07-13       Impact factor: 7.396

5.  Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.

Authors:  Danqing Luo; Jing Yang; Junji Liu; Xia Yong; Zhimin Wang
Journal:  Hereditas       Date:  2022-01-29       Impact factor: 3.271

6.  Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma.

Authors:  Jeroen A A van de Pol; Paranita Ferronika; Helga Westers; Manon van Engeland; Martijn M Terpstra; Kim M Smits; Kim de Lange; Piet A van den Brandt; Rolf H Sijmons; Leo J Schouten; Klaas Kok
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

7.  Sodium content changes between 2015 and 2019 in restaurant menu items selected for sodium reduction in Daegu.

Authors:  Jian Ma; Yeon-Kyung Lee
Journal:  Nutr Res Pract       Date:  2022-01-28       Impact factor: 1.992

8.  Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.

Authors:  Song-Chao Li; Zhan-Kui Jia; Jin-Jian Yang; Xiang-Hui Ning
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

9.  Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.

Authors:  Chuanjie Zhang; Kangjie Shen; Yuxiao Zheng; Feng Qi; Jun Luo
Journal:  Cancer Med       Date:  2019-12-03       Impact factor: 4.452

10.  A DNA methylation signature to improve survival prediction of gastric cancer.

Authors:  Yaojun Peng; Qiyan Wu; Lingxiong Wang; Huan Wang; Fan Yin
Journal:  Clin Epigenetics       Date:  2020-01-20       Impact factor: 6.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.